Literature DB >> 9794420

The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.

D R Moritz1, H R Rodewald, J Gheyselinck, R Klemenz.   

Abstract

Expression of the T1 gene, also known as ST2, DER4, and Fit-1, has been shown to be associated with cell proliferation. It gives rise to two different mRNAs that encode a receptor-like protein and a soluble molecule representing the ectodomain of the receptor form. Although T1 is a member of the IL-1R family, its biologic function is currently unknown. In this study, we have analyzed the expression of the T1 surface Ag in murine hemopoietic organs. Mast cells (MCs) were shown to be the only identifiable cell lineage that expressed T1 at high levels. T1 expression was found on cultured bone marrow-derived immature MCs. Similarly, freshly isolated connective tissue-type MCs from the i.p. cavity were also shown to express high levels of T1. Interestingly, the earliest detectable committed MC precursor isolated from fetal blood (FB) at day 15.5 of gestation, but not circulating hemopoietic stem cells in FB, also expresses high level of T1. Since FB promastocytes lack expression of the high affinity IgE receptor (Fc epsilonRI), T1 expression precedes expression of Fc epsilonRI in MC ontogeny. The finding that the T1 Ag is selectively expressed at several stages during development of the MC lineage suggests that this cell surface molecule, in combination with the well-established markers c-Kit and Fc epsilonRI, should be valuable for studying the MC lineage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

Review 1.  IL-33 family members and asthma - bridging innate and adaptive immune responses.

Authors:  Clare M Lloyd
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

2.  A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis.

Authors:  Pranita Katwa; Xiaojia Wang; Rakhee N Urankar; Ramakrishna Podila; Susana C Hilderbrand; Robert B Fick; Apparao M Rao; Pu Chun Ke; Christopher J Wingard; Jared M Brown
Journal:  Small       Date:  2012-07-06       Impact factor: 13.281

3.  Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells.

Authors:  Regina T Chustz; Deepti R Nagarkar; Julie A Poposki; Silvio Favoreto; Pedro C Avila; Robert P Schleimer; Atsushi Kato
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

4.  Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection.

Authors:  Jose C Alves-Filho; Fabiane Sônego; Fabricio O Souto; Andressa Freitas; Waldiceu A Verri; Maria Auxiliadora-Martins; Anibal Basile-Filho; Andrew N McKenzie; Damo Xu; Fernando Q Cunha; Foo Y Liew
Journal:  Nat Med       Date:  2010-05-16       Impact factor: 53.440

5.  A network map of IL-33 signaling pathway.

Authors:  Sneha M Pinto; Yashwanth Subbannayya; D A B Rex; Rajesh Raju; Oishi Chatterjee; Jayshree Advani; Aneesha Radhakrishnan; T S Keshava Prasad; Mohan R Wani; Akhilesh Pandey
Journal:  J Cell Commun Signal       Date:  2018-04-28       Impact factor: 5.782

6.  GATA-Dependent expression of the interleukin-1 receptor-related T1 gene in mast cells.

Authors:  T Gächter; D R Moritz; J Gheyselinck; R Klemenz
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Authors:  Jennifer Kearley; Karen F Buckland; Sara A Mathie; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

8.  Identification of two distinct subpopulations of Leishmania major-specific T helper 2 cells.

Authors:  Pascale Kropf; Shanti Herath; Rita Tewari; Nelofer Syed; Roman Klemenz; Ingrid Müller
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Soluble ST2 plasma concentrations predict mortality in severe sepsis.

Authors:  Jacobien J Hoogerwerf; Michael W T Tanck; Marieke A D van Zoelen; Xavier Wittebole; Pierre-François Laterre; Tom van der Poll
Journal:  Intensive Care Med       Date:  2010-02-12       Impact factor: 17.440

10.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.